The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day <a target=_blank href= ...
ST. LOUIS (CN) — Express Scripts filed a federal lawsuit against the Federal Trade Commission on Tuesday, claiming its report blaming the pharmacy benefit management industry for rising drug costs ...
Whether Express Scripts wins its unique defamation lawsuit will depend on whether the PBM can prove the FTC made false ...
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.